Pfizer Inc. is looking to sell its remaining stake in Covid-19 vaccine partner BioNTech SE, a remnant from one of the pandemic’s most lucrative collaborations.
Pfizer to Sell Stake in Pandemic Vaccine Partner BioNTech
Related Posts
Investing in Africa: Risks and Opportunities
Global investors are looking at the 54 nations that make up Africa with fresh eyes, not only for their vast…
China’s New Retail Accounts Jump to Highest Since 2024 Boom
China’s stock rally in January drew a rush of momentum-chasing traders, prompting a surge in new account openings.
Khosla-Backed AI Startup Debuts with $80 Million in Funding
Khosla Ventures co-founder Vinod Khosla says he backed AI-startup Reevo because he believes in its founder and CEO, David Zhu.…